Diamond Biofund Inc. (TPE:6901)
Taiwan
· Delayed Price · Currency is TWD 13.85
+0.15 (1.09%)
Apr 28, 2026, 1:30 PM CST
Diamond Biofund Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Other Revenue | -1,073 | -2,229 | -2,440 | 1,016 | 3,064 | Upgrade
|
| Revenue | -1,073 | -2,229 | -2,440 | 1,016 | 3,064 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -66.85% | -52.88% | Upgrade
|
| Gross Profit | -1,073 | -2,229 | -2,440 | 1,016 | 3,064 | Upgrade
|
| Selling, General & Admin | 119.94 | 152.27 | 148.18 | 101.92 | 64.27 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.54 | 0.41 | 0.51 | 0.31 | 0.11 | Upgrade
|
| Operating Expenses | 147.92 | 180.85 | 158.03 | 113.39 | 76.13 | Upgrade
|
| Operating Income | -1,221 | -2,410 | -2,598 | 902.24 | 2,988 | Upgrade
|
| Interest Expense | -3.09 | -3.77 | -0.81 | -0.25 | -0.55 | Upgrade
|
| Interest & Investment Income | 53.09 | 15.15 | 16.24 | 0.86 | 0.12 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.64 | 1.85 | -1.7 | -21.74 | -26.56 | Upgrade
|
| Pretax Income | -1,174 | -2,396 | -2,584 | 881.12 | 2,961 | Upgrade
|
| Income Tax Expense | 0.92 | 121.63 | -0.41 | 83.34 | 108.98 | Upgrade
|
| Net Income | -1,175 | -2,518 | -2,583 | 797.78 | 2,852 | Upgrade
|
| Net Income to Common | -1,175 | -2,518 | -2,583 | 797.78 | 2,852 | Upgrade
|
| Net Income Growth | - | - | - | -72.02% | -53.17% | Upgrade
|
| Shares Outstanding (Basic) | 852 | 850 | 779 | 749 | 804 | Upgrade
|
| Shares Outstanding (Diluted) | 852 | 850 | 779 | 770 | 809 | Upgrade
|
| Shares Change (YoY) | 0.18% | 9.19% | 1.21% | -4.90% | 18.16% | Upgrade
|
| EPS (Basic) | -1.38 | -2.96 | -3.32 | 1.06 | 3.55 | Upgrade
|
| EPS (Diluted) | -1.38 | -2.96 | -3.32 | 1.04 | 3.52 | Upgrade
|
| EPS Growth | - | - | - | -70.45% | -60.43% | Upgrade
|
| Free Cash Flow | -264.25 | 1,125 | -2,587 | 471.63 | -300.42 | Upgrade
|
| Free Cash Flow Per Share | -0.31 | 1.32 | -3.32 | 0.61 | -0.37 | Upgrade
|
| Dividend Per Share | - | - | - | 0.170 | 0.200 | Upgrade
|
| Dividend Growth | - | - | - | -15.33% | - | Upgrade
|
| Gross Margin | - | - | - | 100.00% | 100.00% | Upgrade
|
| Operating Margin | - | - | - | 88.84% | 97.52% | Upgrade
|
| Profit Margin | - | - | - | 78.55% | 93.08% | Upgrade
|
| Free Cash Flow Margin | - | - | - | 46.44% | -9.81% | Upgrade
|
| EBITDA | -1,214 | -2,404 | -2,597 | 903.57 | 2,990 | Upgrade
|
| EBITDA Margin | - | - | - | 88.97% | 97.59% | Upgrade
|
| D&A For EBITDA | 7.41 | 5.95 | 1 | 1.33 | 2.31 | Upgrade
|
| EBIT | -1,221 | -2,410 | -2,598 | 902.24 | 2,988 | Upgrade
|
| EBIT Margin | - | - | - | 88.84% | 97.52% | Upgrade
|
| Effective Tax Rate | - | - | - | 9.46% | 3.68% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.